TECH vs TRU · P/E 65, rev $1.22B vs P/E 19, rev $4.58B
Bio-Techne Corp (TECH) versus TransUnion (TRU) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
TransUnion (TRU) is a financial data & stock exchanges company listed on NYSE.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported TRU revenue for 2025-12-31 was $4.58B. Net income was $455.4M. Revenue was up 9.4% from 2024-12-31 to 2025-12-31. TRU currently screens at market cap $13.41B and trailing P/E 19.3.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. TRU currently screens at market cap $13.41B and trailing P/E 19.3.
Not investment advice. Open the TECH and TRU stock pages for the full models.
Not investment advice.